Here are the 10-Q quarterly reports from Citrine Global Corp (CTGL) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow CTGL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CTGL filings page.
SkyTech Orion Global Corp. reported no revenue for the quarter ended March 31, 2026 and a net loss of $260,000, similar to the prior year’s loss. Operating expenses were driven by $101,000 in research and development and $180,000 in marketing, general and administrative costs.
The balance sheet remains highly leveraged, with total assets of $1.212 million against liabilities of $5.739 million, resulting in a stockholders’ deficit of $4.527 million. Cash stood at only $3,000 and the working capital deficiency was $4.864 million, though management cites access to an Israeli credit facility of NIS 3,000,000 (about $857,000) and other loans extended to September 30, 2027.
The company is repositioning around modular defense and drone technology, led by its SkyTech Replicator™ platform and Replication Manufacturing Method™ for large-scale small drone production. Its Israeli subsidiary was awarded a government grant of NIS 12.5 million (about $4 million) to build the SkyTech Center Israel on 125,000 sq. ft. of company-owned industrial land, supporting future manufacturing and R&D capacity.
SkyTech Orion Global Corp. (CTGL), formerly Citrine Global, filed its quarterly report for the period ended September 30, 2025, showing it is still pre-revenue and investing in a major strategic shift into defense-grade unmanned systems and drone technologies. The company reported a net loss of $1.3 million for the first nine months of 2025, compared with a $1.9 million loss a year earlier, and an accumulated deficit of $33.1 million. Total assets were $1.3 million against total liabilities of $5.2 million, resulting in stockholders’ deficit of $3.9 million, with only $7 thousand in cash.
Shares outstanding rose to 1,234,185,009 as of September 30, 2025, reflecting equity financings and share-based compensation, including about 126 million shares to settle bonuses and fees at $0.001 per share and a $138,000 investment from Deer Light Ltd. The company secured a NIS 12.5 million (about $3.4 million) Israeli government grant to build the SkyTech Innovation and Production Center in Yeruham and extended a credit facility to NIS 1,000,000 (about $280,000). Management highlights a full pivot from wellness into defense and UAV markets, expansion of operations in Israel and the U.S., and ongoing plans for larger capital raises and a potential future uplist, while acknowledging continued losses and dependence on external funding.